Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kandavadivu Umashankar"'
Autor:
Michelle Vu, Sabyasachi Ghosh, Kandavadivu Umashankar, Laura Weber, Christina Landis, Ninfa Candela, Benjamin Chastek
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by relapsing and remitting inflammation that leads to progressive bowel damage. Despite advances in medical treatment for CD, many patients require surgi
Externí odkaz:
https://doaj.org/article/17035832b38c474fb1ceb8c6860deccb
Autor:
Noa Krugliak Cleveland, Niranjan Kathe, Kandavadivu Umashankar, Kirti Mirchandani, Arunima Hait, Riyanka Paul, Sabyasachi Ghosh, Ninfa Candela, Tao Fan, David T. Rubin
Publikováno v:
American Journal of Gastroenterology. 117:e570-e571
Autor:
Kandavadivu Umashankar, Marco Mammi, Ebtissam Badawoud, Yuzhi Tang, Mengqi Zhou, Jorge C. Borges, Aaron Liew, Mattia Migliore, Rania A. Mekary
Publikováno v:
Cardiovascular Drugs and Therapy.
The purpose of this meta-analysis was to compare efficacy and safety of direct oral anticoagulants (DOACs) to warfarin for secondary stroke prevention among adult patients with atrial fibrillation and prior stroke.Major repositories were screened for
Autor:
Noa Cleveland, Benjamin Chastek, Tito Ghosh, Ninfa Candela, Timothy Bancroft, Tao Fan, Kandavadivu Umashankar, David Rubin
Publikováno v:
Gastroenterology. 162:S8-S9
INTRODUCTION Inadequate response, loss of response, or intolerance to a first-line biologic typically requires patients with ulcerative colitis (UC) to switch treatment to a second-line biologic therapy. However, the clinical outcomes of patients rec
Autor:
Niranjan Kathe, Kandavadivu Umashankar, Kirti Mirchandani, Arunima Hait, Riyanka Paul, Tito Ghosh, Ninfa Candela, Tao Fan
Publikováno v:
Inflammatory Bowel Diseases. 28:S9-S10
BACKGROUND In the real-world clinical setting, patients with moderate-to-severe ulcerative colitis (UC) may undergo dose escalation when they lose response to their prescribed biologic treatment. Such dose escalation of biologic agents has an impact
Autor:
Ninfa Candela, Kandavadivu Umashankar, David T. Rubin, Sabyasachi Ghosh, Tao Fan, Benjamin Chastek, Noa Krugliak Cleveland, Timothy Bancroft
Publikováno v:
American Journal of Gastroenterology. 116:S435-S436
Autor:
Noa Krugliak Cleveland, Benjamin Chastek, Sabyasachi Ghosh, Ninfa Candela, Tim Bancroft, Tao Fan, Kandavadivu Umashankar, David T. Rubin
Publikováno v:
Gastroenterology. 162:S-815
Autor:
Gil Melmed, Kandavadivu Umashankar, Tianze Jiao, Tao Fan, Kimberly Krivacic, Niranjan Kathe, Sanjukta Basu, Ninfa Candela
Publikováno v:
Gastroenterology. 162:S-409
Autor:
Noa Krugliak Cleveland, Benjamin Chastek, Sabyasachi Ghosh, Ninfa Candela, Tim Bancroft, Tao Fan, Kandavadivu Umashankar, David T. Rubin
Publikováno v:
Gastroenterology. 162:S-814
Publikováno v:
American Journal of Gastroenterology. 116:S355-S355